Your browser doesn't support javascript.
loading
The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence.
Zhu, Wenlong; McQuarrie, Stuart; Grüschow, Sabine; McMahon, Stephen A; Graham, Shirley; Gloster, Tracey M; White, Malcolm F.
Afiliación
  • Zhu W; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
  • McQuarrie S; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
  • Grüschow S; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
  • McMahon SA; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
  • Graham S; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
  • Gloster TM; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
  • White MF; Biomedical Sciences Research Complex, School of Biology, University of St Andrews, St Andrews KY16 9ST, UK.
Nucleic Acids Res ; 49(5): 2777-2789, 2021 03 18.
Article en En | MEDLINE | ID: mdl-33590098

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleasas / Desoxirribonucleasa I / Proteínas Asociadas a CRISPR / Sistemas CRISPR-Cas Tipo de estudio: Prognostic_studies Idioma: En Revista: Nucleic Acids Res Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ribonucleasas / Desoxirribonucleasa I / Proteínas Asociadas a CRISPR / Sistemas CRISPR-Cas Tipo de estudio: Prognostic_studies Idioma: En Revista: Nucleic Acids Res Año: 2021 Tipo del documento: Article